TABLE 1

Data on Animals with Cerebral Hematoma

Days after bleedingSize of hematoma (mm)18F-FET uptake near hematoma3H-MET uptake near hematoma
Rat no.MRISUVmaxL/BRating*SUVmaxL/BRating*
115.2ND0.660.941.191.32
217.1ND0.691.051.141.30
316.3ND0.901.501.101.38
415.0Gd−0.211.001.170.95
534.3ND1.752.01+2.092.46+
6312.1Gd−0.881.63+2.300.77+
753.9Gd+0.722.25+0.911.65+
853.3ND0.452.37+1.741.34+
963.0Gd+0.652.71+2.391.80+
1072.8ND0.852.43+1.972.29+
1173.4Gd+0.522.17+2.231.52+
1274.5Gd+0.502.27+0.891.68+
1394.8ND1.382.19+NDNDNA
14142.8NDNDNDNA1.551.63+
15144.4NDNDNDNA2.552.93+
16143.7Gd+0.531.77+NDNDNA
17144.6ND0.781.201.500.96
18144.3ND0.411.17NDNDNA
19192.7ND0.721.201.931.61+
20192.0Gd+0.470.730.870.73
21192.3ND0.541.080.870.87
22286.8Gd+0.691.112.131.06
23284.3ND0.501.112.171.48
24281.9Gd+0.631.001.121.02
25284.9ND0.411.321.061.12
Mean4.420.691.571.591.57
SD2.110.330.590.570.55
  • * Plus sign (+) indicates that SUVmax/B > 1.5, minus sign (−) indicates SUVmax/B < 1.5.

  • ND = not done; Gd− = no contrast enhancement in T1-weighted MRI after injection of gadolinium-DTPA; Gd+ = contrast enhancement in T1-weighted MRI after injection of gadolinium-DTPA; L/B = SUVmax near hematoma divided by SUV in normal brain tissue; NA = not applicable.